Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

3M Company (MMM - Analyst Report) through it corporate venture organization, 3M New Ventures, expanded its scope in development of real-time physiological monitoring solutions through its investment in the developer of these solutions, Zephyr Technology. These solutions are used for well-being applications in healthcare, first responder, sports, military, and industrial markets.

Other investors in this series C financing round include Alsop Louie Partners and Motorola Solutions Venture Capital. The invention process of Zephyr includes use of smart fabric sensor technology, original algorithms and system design for developing new ways to monitor human performance.

The biometric sensors monitor ECG, heart rate, breathing rate, estimated core temperature, activity and posture of people. Real-time monitoring by BioSense® analysis algorithms ensures well-being of people.

Markets covered by Zephyr include sports, wellness, defense and medical monitoring. Medical products from Zephyr monitors patients in ambulances and chronic diseases at home and are also used in health management.

3M Company, together with its subsidiaries, operates as a diversified technology firm with manufacturing operations spread over 60 countries worldwide. It has more than 35 business units organized into six segments: Consumer and Office, Display and Graphics, Electro and Communications, Healthcare, Industrial and Transportation, and Safety, Security and Protection Services Business. The major competitors of 3M are Avery Dennison Corporation (AVY - Analyst Report), EI DuPont de Nemours & Co. (DD - Analyst Report) and Johnson & Johnson (JNJ - Analyst Report).

We continue to maintain a Neutral recommendation on 3M Company for the long term while the stock retains a Zacks #4 Rank (Sell Rating) over the next one- to- three months.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GRP IN DXYN 15.84 +7.90%
BOFI HLDG IN BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%